Does DARATUMUMAB Cause Cardiogenic shock? 26 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 26 reports of Cardiogenic shock have been filed in association with DARATUMUMAB (DARZALEX). This represents 0.1% of all adverse event reports for DARATUMUMAB.
26
Reports of Cardiogenic shock with DARATUMUMAB
0.1%
of all DARATUMUMAB reports
9
Deaths
13
Hospitalizations
How Dangerous Is Cardiogenic shock From DARATUMUMAB?
Of the 26 reports, 9 (34.6%) resulted in death, 13 (50.0%) required hospitalization, and 16 (61.5%) were considered life-threatening.
Is Cardiogenic shock Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DARATUMUMAB. However, 26 reports have been filed with the FAERS database.
What Other Side Effects Does DARATUMUMAB Cause?
Plasma cell myeloma (2,980)
Infusion related reaction (2,557)
Off label use (2,494)
Pneumonia (1,450)
Neutropenia (1,351)
Drug ineffective (1,110)
Thrombocytopenia (1,089)
Death (1,088)
Pyrexia (1,032)
Dyspnoea (996)
What Other Drugs Cause Cardiogenic shock?
AMLODIPINE (779)
AMIODARONE (595)
BUPROPION (559)
ACETAMINOPHEN (466)
METOPROLOL (454)
BISOPROLOL (413)
VERAPAMIL (412)
NOREPINEPHRINE (381)
HEPARIN (357)
METFORMIN (356)
Which DARATUMUMAB Alternatives Have Lower Cardiogenic shock Risk?
DARATUMUMAB vs DARATUMUMAB\HYALURONIDASE-FIHJ
DARATUMUMAB vs DARBEPOETIN ALFA
DARATUMUMAB vs DARIDOREXANT
DARATUMUMAB vs DARIFENACIN HYDROBROMIDE
DARATUMUMAB vs DAROLUTAMIDE